Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $246.81 --0%
EPS Growth %: -20.5%
Financial Fact:
Income from operations: 136.25M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -20.5%
Financial Fact:
Income from operations: 136.25M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
- Morgan Stanley Upgrades M&T Bank (MTB) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
